<?xml version="1.0" encoding="UTF-8"?>
<search_results count="1046">
  <query>SEARCH[STUDY] ( Crohn's Disease [STUDY:ALL-FIELDS] )</query>
  <clinical_study>
    <order>801</order>
    <score>0.37261</score>
    <nct_id>NCT02350920</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02350920</url>
    <title>Acceptance and Commitment Therapy (ACT) in Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Behavioral: Acceptance and Committment Therapy (ACT)</intervention_summary>
    <last_changed>May 2, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>802</order>
    <score>0.36946</score>
    <nct_id>NCT00829595</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00829595</url>
    <title>Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Biological: 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM)</intervention_summary>
    <last_changed>January 26, 2009</last_changed>
  </clinical_study>
  <clinical_study>
    <order>803</order>
    <score>0.36785</score>
    <nct_id>NCT02322307</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02322307</url>
    <title>Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Other: HealthPROMISE users; Other: Control Group</intervention_summary>
    <last_changed>June 27, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>804</order>
    <score>0.36658</score>
    <nct_id>NCT00167882</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00167882</url>
    <title>The Influence of 5–Aminosalicylates on Thiopurine Metabolite Levels</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis; Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Drug: 5-aminosalicylate (Pentasa, Ferring)</intervention_summary>
    <last_changed>September 8, 2006</last_changed>
  </clinical_study>
  <clinical_study>
    <order>805</order>
    <score>0.36455</score>
    <nct_id>NCT01145365</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01145365</url>
    <title>Study to Look at Benefit of Surgical Drainage Before Beginning Medical Therapy for Crohns Perianal Fistulas</title>
    <status open="N">Completed</status>
    <condition_summary>Crohns Disease; Fistula; Abscess</condition_summary>
    <intervention_summary>Procedure: Exam under anesthesia (EUA)</intervention_summary>
    <last_changed>April 1, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>806</order>
    <score>0.36432</score>
    <nct_id>NCT01860651</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01860651</url>
    <title>Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease; Ulcerative Colitis; Crohn´s Disease</condition_summary>
    <intervention_summary>Behavioral: Web-monitoring</intervention_summary>
    <last_changed>August 15, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>807</order>
    <score>0.36427</score>
    <nct_id>NCT02858557</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02858557</url>
    <title>The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Crohn's Disease; Dietary Modification</condition_summary>
    <intervention_summary>Behavioral: Mediterranean diet; Behavioral: Specific Carbohydrate Diet</intervention_summary>
    <last_changed>August 5, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>808</order>
    <score>0.36393</score>
    <nct_id>NCT01341808</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01341808</url>
    <title>Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis; Hepatitis A</condition_summary>
    <intervention_summary>Biological: Epaxal Berna (virosomal hepatitis A vaccine)</intervention_summary>
    <last_changed>March 16, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>809</order>
    <score>0.36196</score>
    <nct_id>NCT00283712</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00283712</url>
    <title>Use of Infliximab for the Treatment of Pemphigus Vulgaris</title>
    <status open="N">Completed</status>
    <condition_summary>Pemphigus</condition_summary>
    <intervention_summary>Drug: Infliximab; Drug: Prednisone; Other: Placebo</intervention_summary>
    <last_changed>October 15, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>810</order>
    <score>0.36036</score>
    <nct_id>NCT02476643</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02476643</url>
    <title>Integrative Gastroenterology - an Observational Trial</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Crohns Disease; Ulcerative Colitis; Irritable Bowel Syndrome</condition_summary>
    <intervention_summary>Other: Integrative Therapy</intervention_summary>
    <last_changed>May 22, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>811</order>
    <score>0.35935</score>
    <nct_id>NCT02629211</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02629211</url>
    <title>Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBD</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Colitis, Ulcerative; Crohn Disease</condition_summary>
    <intervention_summary>Device: NaviAid™ AB</intervention_summary>
    <last_changed>August 21, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>812</order>
    <score>0.35919</score>
    <nct_id>NCT02538679</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02538679</url>
    <title>A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques</title>
    <status open="N">Unknown status</status>
    <condition_summary>Crohn's Disease; Inflammatory Bowel Disease; Postoperative Pain</condition_summary>
    <intervention_summary>Drug: bupivacaine; Procedure: Transversus abdominis plane block, ultrasound guided; Procedure: Transversus abdominis plane block, laparoscopic guided</intervention_summary>
    <last_changed>September 1, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>813</order>
    <score>0.35769</score>
    <nct_id>NCT02542917</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02542917</url>
    <title>Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Diseases; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Device: IBDoc home test for faecal calprotectin</intervention_summary>
    <last_changed>September 4, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>814</order>
    <score>0.35501</score>
    <nct_id>NCT01959087</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01959087</url>
    <title>Single Port Colic Laparoscopic Surgery</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Colonic Neoplasms; Crohn's Disease; Diverticulitis</condition_summary>
    <intervention_summary>Procedure: single port surgery; Procedure: Multiport surgery</intervention_summary>
    <last_changed>August 18, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>815</order>
    <score>0.3542</score>
    <nct_id>NCT00587041</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00587041</url>
    <title>Use of Oral Probiotics to Reduce Urinary Oxalate Excretion</title>
    <status open="N">Completed</status>
    <condition_summary>Nephrolithiasis; Hyperoxaluria; Crohn's Disease</condition_summary>
    <intervention_summary>Dietary Supplement: Oxadrop; Dietary Supplement: Agri-King Synbiotic (AKSB); Other: Placebo</intervention_summary>
    <last_changed>April 28, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>816</order>
    <score>0.34626</score>
    <nct_id>NCT02985489</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02985489</url>
    <title>Pre-Operative Parenteral Nutrition in Malnourished Patients</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Malnutrition; Inflammatory Bowel Disease 1</condition_summary>
    <intervention_summary>Dietary Supplement: Olimel Parenteral Nutrition</intervention_summary>
    <last_changed>December 2, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>817</order>
    <score>0.34611</score>
    <nct_id>NCT01099111</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01099111</url>
    <title>Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders</title>
    <status open="N">Completed</status>
    <condition_summary>Irritable Bowel Syndrome; Colitis, Ulcerative; Crohn Disease; Colonic Neoplasms</condition_summary>
    <last_changed>April 24, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>818</order>
    <score>0.34596</score>
    <nct_id>NCT02322008</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02322008</url>
    <title>Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis; Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Biological: infliximab and adalimumab</intervention_summary>
    <last_changed>December 22, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>819</order>
    <score>0.34544</score>
    <nct_id>NCT02620514</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02620514</url>
    <title>Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Behavioral: Education and Reminders; Behavioral: Educational Visit; Behavioral: Medication Educational Visit; Behavioral: Financial Support</intervention_summary>
    <last_changed>January 23, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>820</order>
    <score>0.3443</score>
    <nct_id>NCT02161640</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02161640</url>
    <title>Vascular Dysfunction in Paediatric IBD</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn Disease; Ulcerative Colitis</condition_summary>
    <last_changed>February 22, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>821</order>
    <score>0.34367</score>
    <nct_id>NCT01676324</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01676324</url>
    <title>FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD)</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>June 5, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>822</order>
    <score>0.34304</score>
    <nct_id>NCT01861288</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01861288</url>
    <title>Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease</title>
    <status open="N">Enrolling by invitation</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn Disease; Ulcerative Colitis</condition_summary>
    <last_changed>August 15, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>823</order>
    <score>0.34271</score>
    <nct_id>NCT02073526</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02073526</url>
    <title>Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Drug: Infliximab, adalimumab, certolizumab pegol</intervention_summary>
    <last_changed>December 5, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>824</order>
    <score>0.34229</score>
    <nct_id>NCT02065089</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02065089</url>
    <title>Development of 'Emma'--a Pediatric IBD Quiz</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Ulcerative Colitis; Crohn's Disease; Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Other: playing the ipad quiz game</intervention_summary>
    <last_changed>March 21, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>825</order>
    <score>0.34125</score>
    <nct_id>NCT01990716</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01990716</url>
    <title>Lipid Mediators in Colonic Biopsies as Biomarkers of Disease Activity of Inflammatory Bowel Diseases</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases; Colitis, Ulcerative; Crohn Disease</condition_summary>
    <intervention_summary>Other: Colonic Biopsy</intervention_summary>
    <last_changed>February 21, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>826</order>
    <score>0.34101</score>
    <nct_id>NCT02316678</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02316678</url>
    <title>Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics</title>
    <status open="N">Completed</status>
    <condition_summary>Colitis, Ulcerative; Inflammatory Bowel Diseases; Crohn's Disease</condition_summary>
    <intervention_summary>Other: No intervention</intervention_summary>
    <last_changed>April 17, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>827</order>
    <score>0.3404</score>
    <nct_id>NCT00360022</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00360022</url>
    <title>Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI)</title>
    <status open="N">Terminated</status>
    <condition_summary>Inflammatory Bowel Diseases; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Other: Joint visits</intervention_summary>
    <last_changed>April 1, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>828</order>
    <score>0.3402</score>
    <nct_id>NCT02383953</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02383953</url>
    <title>SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <last_changed>June 16, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>829</order>
    <score>0.33981</score>
    <nct_id>NCT01296841</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01296841</url>
    <title>Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease</condition_summary>
    <intervention_summary>Device: Collaborative Imaging</intervention_summary>
    <last_changed>January 17, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>830</order>
    <score>0.3393</score>
    <nct_id>NCT01505842</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01505842</url>
    <title>Chromoendoscopy for Dysplasia Detection in Chronic Inflammatory Bowel Disease</title>
    <status open="N">Unknown status</status>
    <condition_summary>Ulcerative Colitis; Crohn's Colitis</condition_summary>
    <intervention_summary>Procedure: Colonoscopy with Indigo-Carmine chromoendoscopy; Procedure: Conventional white-light colonoscopy</intervention_summary>
    <last_changed>August 5, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>831</order>
    <score>0.33904</score>
    <nct_id>NCT03079700</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03079700</url>
    <title>Immune Modulation From Trichuris Suis</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn Disease; Ulcerative Colitis; Intestinal Helminthiasis</condition_summary>
    <intervention_summary>Biological: Trichuris suis eggs</intervention_summary>
    <last_changed>March 9, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>832</order>
    <score>0.33904</score>
    <nct_id>NCT02399683</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02399683</url>
    <title>Immune Modulation From Trichuris Trichiura</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn Disease; Colitis, Ulcerative; Intestinal Helminthiasis</condition_summary>
    <intervention_summary>Biological: Trichuris trichiura eggs</intervention_summary>
    <last_changed>November 18, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>833</order>
    <score>0.33674</score>
    <nct_id>NCT01171872</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01171872</url>
    <title>Gene Expression in Inflammatory Bowel Disease</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <last_changed>July 6, 2011</last_changed>
  </clinical_study>
  <clinical_study>
    <order>834</order>
    <score>0.3366</score>
    <nct_id>NCT02828748</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02828748</url>
    <title>Cytokine Production of Colonic Tissue From IBD Patients</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Other: no intervention in patients treatment, only biopsy taken</intervention_summary>
    <last_changed>October 23, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>835</order>
    <score>0.3323</score>
    <nct_id>NCT02752360</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02752360</url>
    <title>Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Colonic Neoplasms; Diverticulosis, Colonic; Crohn Disease</condition_summary>
    <intervention_summary>Procedure: Biodegradable Stenting Anastomoses; Procedure: Double-layer Hand Sutures</intervention_summary>
    <last_changed>June 18, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>836</order>
    <score>0.33035</score>
    <nct_id>NCT00340444</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00340444</url>
    <title>Genetic Studies of Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <last_changed>June 30, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>837</order>
    <score>0.32882</score>
    <nct_id>NCT02754869</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02754869</url>
    <title>Magnetic Resonance Imaging Assessment of Small Bowel Motility</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Motility Disorder of Intestine</condition_summary>
    <last_changed>April 25, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>838</order>
    <score>0.32653</score>
    <nct_id>NCT01169194</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01169194</url>
    <title>Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS): The Search for New Genes</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <last_changed>July 6, 2011</last_changed>
  </clinical_study>
  <clinical_study>
    <order>839</order>
    <score>0.32651</score>
    <nct_id>NCT02085083</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02085083</url>
    <title>Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel Disease</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn Disease; Colitis, Ulcerative</condition_summary>
    <intervention_summary>Behavioral: Telephone and email correspondence with an Inflammatory Bowel Disease Nurse; Behavioral: Minimal Intervention Arm</intervention_summary>
    <last_changed>September 27, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>840</order>
    <score>0.32213</score>
    <nct_id>NCT02847052</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02847052</url>
    <title>Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Other: Non interventional study</intervention_summary>
    <last_changed>July 26, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>841</order>
    <score>0.31915</score>
    <nct_id>NCT01692743</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01692743</url>
    <title>Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis; Indeterminate Colitis</condition_summary>
    <intervention_summary>Behavioral: Home Monitoring; Behavioral: Home Monitoring</intervention_summary>
    <last_changed>May 16, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>842</order>
    <score>0.3131</score>
    <nct_id>NCT02704026</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02704026</url>
    <title>Nutritional Status and Body Composition in Childhood Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Other: Assesment of nutritional status and body composition</intervention_summary>
    <last_changed>March 4, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>843</order>
    <score>0.31114</score>
    <nct_id>NCT00325078</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00325078</url>
    <title>Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease</title>
    <status open="N">Terminated</status>
    <condition_summary>Chronic Granulomatous Disease; Crohn'S-like IBD; Inflammatory Bowel Disease (IBD)</condition_summary>
    <intervention_summary>Drug: Infliximab</intervention_summary>
    <last_changed>November 19, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>844</order>
    <score>0.30485</score>
    <nct_id>NCT02521064</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02521064</url>
    <title>Effects of Exclusive Enteral Nutrition on the Microbiome in Pediatric Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Dietary Supplement: Exclusive Enteral Nutrition (EEN); Drug: Prednisone</intervention_summary>
    <last_changed>April 30, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>845</order>
    <score>0.30468</score>
    <nct_id>NCT02103361</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02103361</url>
    <title>Stelara Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Psoriasis; Pregnancy; Psoriatic Arthritis; Crohn Disease</condition_summary>
    <last_changed>March 22, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>846</order>
    <score>0.30423</score>
    <nct_id>NCT00606346</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00606346</url>
    <title>A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis; Indeterminate Colitis; Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Biological: Anti TNF therapy including infliximab; Drug: No Biologics</intervention_summary>
    <last_changed>June 13, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>847</order>
    <score>0.30376</score>
    <nct_id>NCT01666327</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01666327</url>
    <title>Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Drug: MT-1303</intervention_summary>
    <last_changed>September 4, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>848</order>
    <score>0.30113</score>
    <nct_id>NCT02822235</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02822235</url>
    <title>Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Other: No Intervention</intervention_summary>
    <last_changed>March 9, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>849</order>
    <score>0.30005</score>
    <nct_id>NCT01140802</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01140802</url>
    <title>Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their Relatives</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <last_changed>April 23, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>850</order>
    <score>0.29886</score>
    <nct_id>NCT00514982</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00514982</url>
    <title>Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome</title>
    <status open="N">Withdrawn</status>
    <condition_summary>Hermanski-Pudlak Syndrome; Colitis; Cytokines; Lymphocytes; Drug Evaluation</condition_summary>
    <intervention_summary>Drug: Mesalamine; Drug: Infliximab; Drug: Corticosteroids; Drug: 6-Mercaptopurine; Drug: Tacrolimus; Drug: Adalimumab</intervention_summary>
    <last_changed>June 30, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>851</order>
    <score>0.29751</score>
    <nct_id>NCT02760940</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02760940</url>
    <title>Anemia in Inflammatory Bowel Disease</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>Anemia; Bowel Diseases, Inflammatory</condition_summary>
    <intervention_summary>Drug: oral liposomal iron</intervention_summary>
    <last_changed>August 7, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>852</order>
    <score>0.29638</score>
    <nct_id>NCT02182947</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02182947</url>
    <title>Capsule Endoscopy in Inflammatory Bowel Disease (IBD) in Children</title>
    <status open="N">Unknown status</status>
    <condition_summary>IBD</condition_summary>
    <intervention_summary>Device: Capsule endoscopy</intervention_summary>
    <last_changed>July 2, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>853</order>
    <score>0.29094</score>
    <nct_id>NCT01162889</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01162889</url>
    <title>Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People</title>
    <status open="N">Terminated</status>
    <condition_summary>Healthy</condition_summary>
    <intervention_summary>Drug: Placebo SC Injection; Drug: ATR-107 (PF-05230900) SC Injection; Drug: ATR-107 (PF-05230900) SC Injection; Drug: ATR-107 (PF-05230900) SC Injection; Drug: ATR-107 (PF-05230900) SC Injection; Drug: ATR-107 (PF-05230900) SC Injection; Drug: ATR-107 (PF-05230900) IV Infusion; Drug: ATR-107 (PF-05230900) IV Infusion; Drug: ATR-107 (PF-05230900) IV Infusion; Drug: Placebo IV Infusion; Drug: ATR-107 (PF-05230900) IV Infusion</intervention_summary>
    <last_changed>March 13, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>854</order>
    <score>0.28954</score>
    <nct_id>NCT02636517</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02636517</url>
    <title>Fecal Microbiome Transplant</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Clostridium Difficile; Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Biological: Fecal Microbiota Transplant</intervention_summary>
    <last_changed>January 9, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>855</order>
    <score>0.28823</score>
    <nct_id>NCT02466217</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02466217</url>
    <title>Phenomics in Autoimmune and Inflammatory Diseases</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Healthy Volunteer; Rheumatoid Arthritis; Ankylosing Spondylitis; Systemic Lupus Erythematosus/Antiphospholipid Syndrome; FMF; Cryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic Syndrome; Vasculitis; Uveitis; Myositis; Crohn's Disease; Ulcerative Rectocolitis; Type 1 Diabetes; Unclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy</condition_summary>
    <intervention_summary>Other: 1: AID groups; Other: 2: Control groups</intervention_summary>
    <last_changed>December 12, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>856</order>
    <score>0.28809</score>
    <nct_id>NCT00769353</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00769353</url>
    <title>Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease; Depression</condition_summary>
    <intervention_summary>Behavioral: Primary and Secondary Coping Enhancement Training; Behavioral: Supportive Non-directive Therapy</intervention_summary>
    <last_changed>May 20, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>857</order>
    <score>0.28769</score>
    <nct_id>NCT01947036</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01947036</url>
    <title>T and B Cell Responses in Autoimmune Diseases</title>
    <status open="N">Terminated</status>
    <condition_summary>Type 1 Diabetes Mellitus; Multiple Sclerosis; Arthritis, Rheumatoid; Crohn's Disease; Psoriasis</condition_summary>
    <last_changed>October 24, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>858</order>
    <score>0.28658</score>
    <nct_id>NCT02790281</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02790281</url>
    <title>A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Procedure: Blood sampling</intervention_summary>
    <last_changed>January 13, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>859</order>
    <score>0.28406</score>
    <nct_id>NCT02364973</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02364973</url>
    <title>Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study</title>
    <status open="Y">Recruiting</status>
    <condition_summary>IBD</condition_summary>
    <intervention_summary>Other: PET-MRI</intervention_summary>
    <last_changed>November 3, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>860</order>
    <score>0.28123</score>
    <nct_id>NCT02076750</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02076750</url>
    <title>Weekly Vitamin D in Pediatric IBD</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases; Skin Pigmentation</condition_summary>
    <intervention_summary>Dietary Supplement: Vitamin D3 (cholecalciferol)</intervention_summary>
    <last_changed>November 25, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>861</order>
    <score>0.28029</score>
    <nct_id>NCT00248742</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00248742</url>
    <title>Psychobiology in Inflammatory Bowel Disease(IBD)</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Behavioral: Psychological behavioral intervention</intervention_summary>
    <last_changed>July 3, 2011</last_changed>
  </clinical_study>
  <clinical_study>
    <order>862</order>
    <score>0.27687</score>
    <nct_id>NCT03209700</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03209700</url>
    <title>Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas</title>
    <status open="N">Enrolling by invitation</status>
    <condition_summary>Perianal Fistula; Cryptoglandular Perianal Fistula; Crohn's Perianal Fistula</condition_summary>
    <intervention_summary>Drug: MSC-AFP</intervention_summary>
    <last_changed>July 13, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>863</order>
    <score>0.27659</score>
    <nct_id>NCT01787825</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01787825</url>
    <title>Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Intestinal Disease; Inflammatory Bowel Disease; Crohn Disease; Ulcer; Celiac Disease</condition_summary>
    <intervention_summary>Device: PillCam SB2 capsule; Device: CapsoCam SV-1</intervention_summary>
    <last_changed>March 31, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>864</order>
    <score>0.27586</score>
    <nct_id>NCT00152620</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00152620</url>
    <title>Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease</title>
    <status open="N">Terminated</status>
    <condition_summary>Inflammatory Bowel Disease (IBD)</condition_summary>
    <intervention_summary>Drug: Dexamethasone; Drug: Methylprednisolone</intervention_summary>
    <last_changed>September 4, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>865</order>
    <score>0.27532</score>
    <nct_id>NCT01910792</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01910792</url>
    <title>Ultraviolet Light And Vitamin D In Subjects With Fat Malabsorption Or After Gastric Bypass Surgery</title>
    <status open="N">Completed</status>
    <condition_summary>Vitamin D Deficiency; Gastrointestinal Diseases</condition_summary>
    <intervention_summary>Device: Sperti Lamp</intervention_summary>
    <last_changed>June 12, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>866</order>
    <score>0.27471</score>
    <nct_id>NCT02152241</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02152241</url>
    <title>Long-term Functional Outcome of Children With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <last_changed>October 24, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>867</order>
    <score>0.27385</score>
    <nct_id>NCT01174186</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01174186</url>
    <title>Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing</title>
    <status open="N">Completed</status>
    <condition_summary>Spondyloarthritis; Enterocolitis</condition_summary>
    <intervention_summary>Drug: Adalimumab</intervention_summary>
    <last_changed>November 18, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>868</order>
    <score>0.27169</score>
    <nct_id>NCT03145896</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03145896</url>
    <title>The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients</title>
    <status open="Y">Not yet recruiting</status>
    <condition_summary>IBD</condition_summary>
    <intervention_summary>Dietary Supplement: vitamin D</intervention_summary>
    <last_changed>May 8, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>869</order>
    <score>0.27083</score>
    <nct_id>NCT01966744</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01966744</url>
    <title>Self-Management Assistance for Recommended Treatment (SMART) Portal</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis; Indeterminate Colitis; Inflammatory Bowel Disease</condition_summary>
    <last_changed>July 18, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>870</order>
    <score>0.26984</score>
    <nct_id>NCT02503514</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02503514</url>
    <title>Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Crohns Disease; Ulcerative Colitis; Colitis</condition_summary>
    <last_changed>April 12, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>871</order>
    <score>0.26562</score>
    <nct_id>NCT01536509</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01536509</url>
    <title>Improving Medication Adherence in Pediatric Inflammatory Bowel Disease</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Crohn's Disease; Ulcerative Colitis; Indeterminate Colitis; Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Behavioral: Telehealth Behavioral Treatment (TBT); Behavioral: Education Only (EO)</intervention_summary>
    <last_changed>September 21, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>872</order>
    <score>0.26456</score>
    <nct_id>NCT02998398</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02998398</url>
    <title>Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Rheumatoid Arthritis; Spondyloarthritis; Crohn's Disease; Uveitis</condition_summary>
    <intervention_summary>Other: Switch from REMICADE® to INFLECTRA®</intervention_summary>
    <last_changed>December 15, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>873</order>
    <score>0.26369</score>
    <nct_id>NCT01019837</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01019837</url>
    <title>Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Inflammatory Bowel Diseases (IBD) Treated Immunomodulators and Biologics</title>
    <status open="N">Unknown status</status>
    <condition_summary>Influenza H1N1</condition_summary>
    <intervention_summary>Biological: Focetria (Monovalent MF59-Adjuvanted vaccine)</intervention_summary>
    <last_changed>November 23, 2009</last_changed>
  </clinical_study>
  <clinical_study>
    <order>874</order>
    <score>0.2614</score>
    <nct_id>NCT02778464</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02778464</url>
    <title>Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Disease (IBD); Crohn's Disease (CD); Ulcerative Colitis (UC); Pregnancy</condition_summary>
    <last_changed>June 20, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>875</order>
    <score>0.26107</score>
    <nct_id>NCT00490048</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00490048</url>
    <title>Assessment of Pulmonary Involvement inUlcerative Colitis by Induced Sputum</title>
    <status open="N">Completed</status>
    <condition_summary>Ulcerative Colitis</condition_summary>
    <intervention_summary>Procedure: Induced sputum (inhalation of 3.5% saline)</intervention_summary>
    <last_changed>June 21, 2007</last_changed>
  </clinical_study>
  <clinical_study>
    <order>876</order>
    <score>0.26007</score>
    <nct_id>NCT01866774</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01866774</url>
    <title>Evaluation of Fecal Calprotectin Screening and a Gastroenterology Questionnaire for Triaging Children With Chronic Abdominal Pain and/or Diarrhea Referred to a Pediatric Gastroenterology Service</title>
    <status open="N">Terminated</status>
    <condition_summary>Chronic Abdominal Pain; Chronic Diarrhea</condition_summary>
    <intervention_summary>Other: Fecal calprotectin level</intervention_summary>
    <last_changed>October 22, 2015</last_changed>
  </clinical_study>
  <clinical_study>
    <order>877</order>
    <score>0.25919</score>
    <nct_id>NCT01981889</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01981889</url>
    <title>Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease 11</condition_summary>
    <intervention_summary>Drug: Prednisone</intervention_summary>
    <last_changed>October 31, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>878</order>
    <score>0.25707</score>
    <nct_id>NCT03116568</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03116568</url>
    <title>Bacterial Transmission In Utero and IBD Risk</title>
    <status open="Y">Recruiting</status>
    <condition_summary>IBD; Pregnancy Related; Microbiota</condition_summary>
    <last_changed>April 28, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>879</order>
    <score>0.25617</score>
    <nct_id>NCT02952131</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02952131</url>
    <title>Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Procedure: Lipoaspiration; Procedure: AD-cSVF; Procedure: Normal Saline IV</intervention_summary>
    <last_changed>March 6, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>880</order>
    <score>0.25527</score>
    <nct_id>NCT02478944</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02478944</url>
    <title>Esophageal Motility Disease Screening in Patient With Suspicion or Diagnosis of IBD</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Device: Manometry</intervention_summary>
    <last_changed>June 29, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>881</order>
    <score>0.25446</score>
    <nct_id>NCT00791557</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00791557</url>
    <title>Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Pyoderma Gangrenosum; Crohn's Disease; Ulcerative Colitis; Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Drug: Infliximab</intervention_summary>
    <last_changed>September 27, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>882</order>
    <score>0.25379</score>
    <nct_id>NCT01011244</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01011244</url>
    <title>Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula</title>
    <status open="N">Completed</status>
    <condition_summary>Crohn's Fistula</condition_summary>
    <intervention_summary>Biological: ADIPOPLUS</intervention_summary>
    <last_changed>March 14, 2012</last_changed>
  </clinical_study>
  <clinical_study>
    <order>883</order>
    <score>0.25223</score>
    <nct_id>NCT01095042</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01095042</url>
    <title>Cognition and Emotion in the SII and IBD</title>
    <status open="N">Completed</status>
    <condition_summary>Irritable Bowel Syndrome; Inflammatory Bowel Disease (IBD); Crohn's Disease(CD); Ulcerative Colitis</condition_summary>
    <intervention_summary>Behavioral: emotion</intervention_summary>
    <last_changed>January 27, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>884</order>
    <score>0.25211</score>
    <nct_id>NCT00035074</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00035074</url>
    <title>A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Drug: Methotrexate</intervention_summary>
    <last_changed>June 23, 2005</last_changed>
  </clinical_study>
  <clinical_study>
    <order>885</order>
    <score>0.25189</score>
    <nct_id>NCT03011593</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03011593</url>
    <title>Effect of UGIR in Adults With Compromised Gut Function and Malabsorption</title>
    <status open="N">Completed</status>
    <condition_summary>Irritable Bowel Syndrome; Crohn Disease; Ulcerative Colitis; Celiac Disease</condition_summary>
    <intervention_summary>Other: Nutrition Support Product</intervention_summary>
    <last_changed>January 3, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>886</order>
    <score>0.25138</score>
    <nct_id>NCT02896530</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02896530</url>
    <title>Arterial Thrombosis and Inflammatory Bowel Disease: a Series of 6 Cases and Literature Review</title>
    <status open="N">Completed</status>
    <condition_summary>Arterial Thrombosis</condition_summary>
    <intervention_summary>Other: No intervention. Description study</intervention_summary>
    <last_changed>September 6, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>887</order>
    <score>0.24914</score>
    <nct_id>NCT00468455</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00468455</url>
    <title>Post-Op Quality of Life After Colorectal Surgery</title>
    <status open="N">Completed</status>
    <condition_summary>Colorectal Neoplasms; Colitis, Ulcerative; Diverticulitis; Colonic Polyps; Crohn Disease</condition_summary>
    <intervention_summary>Procedure: Laparoscopic or open colorectal surgery</intervention_summary>
    <last_changed>December 12, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>888</order>
    <score>0.24878</score>
    <nct_id>NCT03134508</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03134508</url>
    <title>Population Based Evaluation of the Use of TNFα Antagonists in Pregnant Women With Inflammatory Bowel Diseases</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Other: treated by antiTNFα; Other: not treated by antiTNFα</intervention_summary>
    <last_changed>April 28, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>889</order>
    <score>0.24774</score>
    <nct_id>NCT03053414</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03053414</url>
    <title>Vitamin D Repletion and Maintenance in IBD: How Much and How Often</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Vitamin D Deficiency</condition_summary>
    <intervention_summary>Dietary Supplement: Vitamin D (ergocalciferol and/ or cholecalciferol)</intervention_summary>
    <last_changed>February 10, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>890</order>
    <score>0.24712</score>
    <nct_id>NCT02909244</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02909244</url>
    <title>Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Primary Immune Deficiencies</condition_summary>
    <intervention_summary>Biological: Biological sampling</intervention_summary>
    <last_changed>September 16, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>891</order>
    <score>0.24676</score>
    <nct_id>NCT01854242</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01854242</url>
    <title>Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease</title>
    <status open="N">Completed</status>
    <condition_summary>Inflammatory Bowel Disease; Glycogen Storage Disease Type Ia</condition_summary>
    <intervention_summary>Other: Glycogen Storage Disease type Ia patients</intervention_summary>
    <last_changed>December 22, 2014</last_changed>
  </clinical_study>
  <clinical_study>
    <order>892</order>
    <score>0.24549</score>
    <nct_id>NCT02771457</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02771457</url>
    <title>Managing Infliximab Reinduction After Temporary Discontinuation of Drug</title>
    <status open="N">Withdrawn</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Drug: Infliximab at weeks 0,2, and 6; Drug: Infliximab at weeks 0,4, and 8; Drug: Infliximab at weeks 0 and 8</intervention_summary>
    <last_changed>June 29, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>893</order>
    <score>0.24504</score>
    <nct_id>NCT00604864</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT00604864</url>
    <title>Effect of Anti TNFa Upon Deep Endometriosis Associated Pain</title>
    <status open="N">Completed</status>
    <condition_summary>Endometriosis</condition_summary>
    <intervention_summary>Drug: anti TNFa monoclonal antibody - Infliximab; Drug: placebo</intervention_summary>
    <last_changed>January 29, 2008</last_changed>
  </clinical_study>
  <clinical_study>
    <order>894</order>
    <score>0.24426</score>
    <nct_id>NCT01771224</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01771224</url>
    <title>Effect of FAn-7 in UC Activity</title>
    <status open="N">Unknown status</status>
    <condition_summary>Inflammatory Bowel Disease; Ulcerative Colitis</condition_summary>
    <intervention_summary>Dietary Supplement: Palmitoleic acid</intervention_summary>
    <last_changed>January 16, 2013</last_changed>
  </clinical_study>
  <clinical_study>
    <order>895</order>
    <score>0.24377</score>
    <nct_id>NCT01650311</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT01650311</url>
    <title>Investigating Serotonin Signalling in IBD Patients</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <last_changed>March 22, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>896</order>
    <score>0.24367</score>
    <nct_id>NCT02351635</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02351635</url>
    <title>BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Disease; Irritable Bowel Syndrome</condition_summary>
    <intervention_summary>Other: fecal calprotectin level</intervention_summary>
    <last_changed>July 12, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>897</order>
    <score>0.24322</score>
    <nct_id>NCT03056924</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT03056924</url>
    <title>Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases</condition_summary>
    <intervention_summary>Biological: Pneumococcal Pneumonia vaccine; Biological: Influenza vaccine; Biological: Hepatitis B vaccine</intervention_summary>
    <last_changed>July 10, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>898</order>
    <score>0.24249</score>
    <nct_id>NCT02460705</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02460705</url>
    <title>Fecal Microbiota Transplant for Inflammatory Bowel Disease</title>
    <status open="N">Active, not recruiting</status>
    <condition_summary>Inflammatory Bowel Disease</condition_summary>
    <intervention_summary>Drug: Biologically active human fecal material, OpenBiome</intervention_summary>
    <last_changed>November 1, 2016</last_changed>
  </clinical_study>
  <clinical_study>
    <order>899</order>
    <score>0.24206</score>
    <nct_id>NCT02884557</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02884557</url>
    <title>NKT Role in the Regulation of the Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Diseases; Primary Sclerosing Cholangitis</condition_summary>
    <intervention_summary>Other: collection of gut biopsies collection of blood samples</intervention_summary>
    <last_changed>February 20, 2017</last_changed>
  </clinical_study>
  <clinical_study>
    <order>900</order>
    <score>0.24171</score>
    <nct_id>NCT02461784</nct_id>
    <url>https://ClinicalTrials.gov/show/NCT02461784</url>
    <title>The Effect of Methotrexate on Sperm Quality in Men With Inflammatory Bowel Disease</title>
    <status open="Y">Recruiting</status>
    <condition_summary>Inflammatory Bowel Disease (IBD)</condition_summary>
    <intervention_summary>Procedure: Semen &amp; Data Collection</intervention_summary>
    <last_changed>October 31, 2016</last_changed>
  </clinical_study>
</search_results>
